{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:57:13Z","timestamp":1789610233445,"version":"build-2803163510"},"reference-count":48,"publisher":"American Society for Microbiology","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      A wide variety of clinically observed amino acid alterations in the\n                      <jats:italic toggle=\"yes\">Pseudomonas aeruginosa<\/jats:italic>\n                      chromosomal \u03b2-lactamase AmpC (\n                      <jats:italic toggle=\"yes\">Pseudomonas<\/jats:italic>\n                      -derived cephalosporinase [PDC]) are associated with increased resistance to cefepime, ceftolozane\/tazobactam, or ceftazidime\/avibactam, but their impact on cefiderocol resistance is unclear. We took advantage of a previously engineered collection of wild-type (PAO1) and iron uptake-deficient (PAO \u0394\n                      <jats:italic toggle=\"yes\">piuC<\/jats:italic>\n                      )\n                      <jats:italic toggle=\"yes\">P. aeruginosa<\/jats:italic>\n                      isolates producing 19 distinct PDC variants with substitutions in key catalytic regions. While most variants had moderate effects on cefiderocol minimum inhibitory concentrations compared to PDC-1, the E219K (\u2126-loop) and L293P (helix H10) variants significantly affected cefiderocol activity. Kinetic studies revealed that both mutations improve cefiderocol hydrolysis through different enzymatic mechanisms compared to PDC-1 (\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 85.29 \u00b5M,\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      = 0.0036 s\n                      <jats:sup>\u22121<\/jats:sup>\n                      , and\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      \/\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 0.00004 \u00b5M\n                      <jats:sup>\u22121<\/jats:sup>\n                      s\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), leading to enhanced turnover in PDC E219K (\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 465.64 \u00b5M,\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      = 0.45 s\n                      <jats:sup>\u22121<\/jats:sup>\n                      , and\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      \/\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 0.00096 \u00b5M\n                      <jats:sup>\u22121<\/jats:sup>\n                      s\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) and improved affinity in PDC L293P (\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 2.69 \u00b5M,\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      = 0.0036 s\n                      <jats:sup>\u22121<\/jats:sup>\n                      , and\n                      <jats:italic toggle=\"yes\">k<\/jats:italic>\n                      <jats:sub>cat<\/jats:sub>\n                      \/\n                      <jats:italic toggle=\"yes\">K<\/jats:italic>\n                      <jats:sub>m<\/jats:sub>\n                      = 0.00135 \u00b5M\n                      <jats:sup>\u22121<\/jats:sup>\n                      s\n                      <jats:sup>\u22121<\/jats:sup>\n                      ). These mechanisms are also involved in resistance to ceftolozane and cefepime, identified as the preferred substrates for the E219K and L293P variants, respectively. Molecular dynamics (MD) simulation studies revealed that (i) rigidification of the \u03a9-loop in PDC E219K promotes optimal accommodation of the R\n                      <jats:sup>1<\/jats:sup>\n                      group of cefiderocol, enhancing nucleophilic attack by the catalytic serine; (ii) the less folded conformation of helix H10 in PDC L293P improves cefiderocol accommodation in the active site by establishing stronger hydrogen-bonding interactions with the R\n                      <jats:sup>2<\/jats:sup>\n                      group. Our findings demonstrate that the PDC \u03b2-lactamase may take advantage of the structural similarities between cefiderocol and other cephalosporins and accelerate hydrolysis by accommodating the E219K or L293P amino acid replacements.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00292-25","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:00:27Z","timestamp":1748336427000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Functional and structural analyses of amino acid sequence variation in PDC \u03b2-lactamase reveal different mechanistic pathways toward cefiderocol resistance in\n                    <i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8387-3784","authenticated-orcid":false,"given":"Luc\u00eda","family":"Gonz\u00e1lez-Pinto","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-5674","authenticated-orcid":false,"given":"Mar\u00eda Antonia","family":"Gomis-Font","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05jmd4043","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa), Hospital Universitario Son Espases","place":["Palma de Mallorca, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9489-9421","authenticated-orcid":false,"given":"Emilio","family":"Lence","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/030eybx10","id-type":"ROR","asserted-by":"publisher"}],"name":"Centro Singular de Investigaci\u00f3n en Qu\u00edmica Biol\u00f3xica e Materiais Moleculares (CiQUS), Departamento de Qu\u00edmica Org\u00e1nica, Universidade de Santiago de Compostela","place":["Santiago de Compostela, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-0239","authenticated-orcid":false,"given":"Michelle","family":"Outeda-Garc\u00eda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1636-6429","authenticated-orcid":false,"given":"Tania","family":"Blanco-Mart\u00edn","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8270-0259","authenticated-orcid":false,"given":"Salud","family":"Rodr\u00edguez-Pallares","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5696-5812","authenticated-orcid":false,"given":"Luc\u00eda","family":"S\u00e1nchez-Pe\u00f1a","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-969X","authenticated-orcid":false,"given":"Isaac","family":"Alonso-Garc\u00eda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-0779","authenticated-orcid":false,"given":"Juan Carlos","family":"V\u00e1zquez-Ucha","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-7815","authenticated-orcid":true,"given":"Alejandro","family":"Beceiro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-0062","authenticated-orcid":true,"given":"Germ\u00e1n","family":"Bou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-553X","authenticated-orcid":false,"given":"Concepci\u00f3n","family":"Gonz\u00e1lez-Bello","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/030eybx10","id-type":"ROR","asserted-by":"publisher"}],"name":"Centro Singular de Investigaci\u00f3n en Qu\u00edmica Biol\u00f3xica e Materiais Moleculares (CiQUS), Departamento de Qu\u00edmica Org\u00e1nica, Universidade de Santiago de Compostela","place":["Santiago de Compostela, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9327-1894","authenticated-orcid":true,"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05jmd4043","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa), Hospital Universitario Son Espases","place":["Palma de Mallorca, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-503X","authenticated-orcid":true,"given":"Jorge","family":"Arca-Su\u00e1rez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044knj408","id-type":"ROR","asserted-by":"publisher"}],"name":"Servicio de Microbiolog\u00eda & Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario A Coru\u00f1a","place":["A Coru\u00f1a, Spain"]},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00685"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00329-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000966"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02462-13"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa291"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02067-21"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad062"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01695-15"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01454-17"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz826"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad396"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106917"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03836-23"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01192-23"},{"key":"e_1_3_3_16_2","unstructured":"Pseudomonas aeruginosa derived cephalosporinase (PDC) database. Antibiotic resistance and pathogenicity of bacterial infections group \u2013 IdISBa. 2023. Available from: https:\/\/arpbigidisba.com\/pseudomonas-aeruginosa-derived-cephalosporinase-pdc-database\/"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00825-15"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae326"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.05.011"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01117-20"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01841-19"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02247-12"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00369"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0897"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi0109358"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac241"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx424"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab311"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad172"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.1040-1042.2004"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00894-20"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky317"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00791-23"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02085-18"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01409-22"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.04.578824"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1966-1970.2002"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa355"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00198-20"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01479-12"},{"key":"e_1_3_3_41_2","volume-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100","author":"CLSI","year":"2020","unstructured":"CLSI. 2020. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 30th ed. Clinical and Laboratory Standards Institute.","edition":"30"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01172-17"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03098-15"},{"key":"e_1_3_3_44_2","unstructured":"Case DA Aktulga HM Belfon K Ben-Shalom IY Brozell SR Cerutti DS Cheatham TE Cisneros GA Cruzeiro VWD Darden TA Duke RE Giambasu G. 2021. AMBER. University of California San Francisco"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.3c01153"},{"key":"e_1_3_3_46_2","unstructured":"DeLano WL. 2008. The PyMOL molecular graphics system. DeLano Scientific LLC. Available from: http:\/\/www.pymol.org\/"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792"},{"key":"e_1_3_3_48_2","unstructured":"FrischMJ TrucksGW SchlegelHB ScuseriaGE RobbMA Cheeseman JR Scalmani G BaroneV MennucciB PeterssonGA. 2009. Gaussian 09 Revision D.01 Gaussian Inc.: Wallingford CT"},{"key":"e_1_3_3_49_2","unstructured":"AMBER. 2015. London workshop. Introduction to principal component analysis. Available from: http:\/\/www.amber.utah.edu\/AMBER-workshop\/London-2015\/pca\/"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00292-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00292-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:00:29Z","timestamp":1748336429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00292-25"}},"subtitle":[],"editor":[{"given":"Cesar A.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":48,"alternative-id":["10.1128\/aac.00292-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.00292-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"2025-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00292-25"}}